Krystal Biotech Inc (KRYS)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 818,355 | 558,450 | 626,295 | 310,844 | 209,023 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $818,355K
= 0.00
Krystal Biotech Inc has consistently maintained a debt-to-assets ratio of 0.00 over the past five years, indicating that the company has not relied on debt financing to fund its operations or investments during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely financed by equity or internal funding sources. While a low or zero debt-to-assets ratio can be viewed positively as it signifies a lower financial risk and greater financial stability, it is essential to consider the overall financial health and growth strategy of the company in conjunction with this ratio. Further analysis of the company's financial statements and future projections would provide a more comprehensive understanding of Krystal Biotech Inc's financial position and strategic direction.
Peer comparison
Dec 31, 2023